Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026)

Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Other Non Operating Income came in at $76264.0 in Q1 2026, up 2785.51% year-on-year from $2643.0 in Q1 2025, and down 76.6% quarter-over-quarter from $325907.0 in Q4 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Other Non Operating Income (2021 - 2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $76264.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 2785.51% year-over-year to $76264.0 in Q1 2026; TTM through Mar 2026 was $416271.0, a 15.45% increase from a year earlier, with the FY2025 full-year figure at $342650.0, down 38.35% from the prior year.
  • Other Non Operating Income slipped to $76264.0 in Q1 2026 per SHPH's latest filing, from $325907.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.2 million in Q1 2023 and bottomed at -$517687.0 in Q4 2022.
  • The 5-year median for Other Non Operating Income is $98313.0 (2023), against an average of $162795.8.
  • Across the five-year window, Other Non Operating Income soared 3029.89% in 2023 and tumbled 133.11% in 2024, its largest moves.
  • Year by year, Other Non Operating Income stood at -$517687.0 in 2022, then jumped by 118.99% to $98313.0 in 2023, then soared by 119.08% to $215384.0 in 2024, then soared by 51.31% to $325907.0 in 2025, then sank by 76.6% to $76264.0 in 2026.
  • Per Business Quant, the three latest SHPH Other Non Operating Income figures stand at $76264.0 (Q1 2026), $325907.0 (Q4 2025), and $2427.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Shuttle Pharmaceuticals Holdings 120,186.04 120,186.04 -

Historic Data

Download Data
DateValue
Mar 31, 2026 76,264.00
Dec 31, 2025 325,907.00
Sep 30, 2025 2,427.00
Jun 30, 2025 11,673.00
Mar 31, 2025 2,643.00
Dec 31, 2024 215,384.00
Sep 30, 2024 286,316.00
Jun 30, 2024 -143,773.00
Mar 31, 2024 197,862.00
Dec 31, 2023 98,313.00
Sep 30, 2023 442,900.00
Jun 30, 2023 434,275.00
Mar 31, 2023 1.24 Mn
Dec 31, 2022 -517,687.00
Sep 30, 2022 112,797.00
Jun 30, 2022 -58,422.00
Mar 31, 2022 39,650.00
Sep 30, 2021 62,500.00